Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...
Addiction specialist Richard Taite explained to Us Weekly how stars like Liam Payne end up seeking treatment for drug use ...
NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...
Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care ...
In a pioneering study, study, researchers have demonstrated that metformin, a common diabetes drug, can slow the growth of ...
One of two new studies found most patients doing well six years after treatment. Another study found blood cancers in 17% of ...
All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective ...
Meet 10 of our spinouts, all committed to changing the story of cancer. Astex's FBDD approach has led to the approval of ...
Neuroinflammation drives the progression of neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis. Targeting neuroinflammation with small molecules is promising, but ...
BMB-201 demonstrated dose-dependent efficacy in pain modelsBMB-201 demonstrated similar efficacy to morphine in several pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback